1 / 10

Xovoltib 40mg | Xovoltib 40mg tablets, dose | Apple pharmaceuticals

Xovoltib 40mg belongs to quinazoline and butanamide derivative which acts as a tyrosine kinase inhibitor of epidermal growth factor receptors (ERBB RECEPTORS) and is used in the treatment of metastatic NON-SMALL CELL LUNG CANCER.<br>

Emimadi
Télécharger la présentation

Xovoltib 40mg | Xovoltib 40mg tablets, dose | Apple pharmaceuticals

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Xovoltib 40mg tablets | Afatinib 40mg tablet Apple pharmaceuticals

  2. Xovoltib 40mg tablets (Afatinib) • Xovoltib40mg belongs to quinazoline and butanamide derivative which acts as a tyrosine kinase inhibitor of epidermal growth factor receptors (ERBB RECEPTORS) and is used in the treatment of metastatic NON-SMALL CELL LUNG CANCER. • Xovoltib40mg is a prescription drugs which is used under the guidance of medical practioners • Xovoltib 40mg is indicated for treatment a certain type of lung cancer (non-small cell lung cancer) which has spread to other parts of the body.

  3. DOSAGE For adult : • The prescribed dose is 40mg taken once per day. For child dosage : • Ages of 0-17 years is not being studied in children.  • The drug should not be used age under 18 years of age For renal impairment: • prescribed dose is 30mg taken once per day • Take Xovoltib on an empty stomach. Consume the drug 1 hour before or 2 hours after a meal  • Avoid cutting or crushing the tablet.

  4. MECHANISM • Xovoltib 20mg blocking the activating sites called tyrosine kinases of various proteins within the cell. • These proteins are most likely to develop cancer growth when the tumor includes the EGFR gene mutation. • By stopping these targets, it will target the cancer will shrink.

  5. PRECAUTIONS Keratitis: •  if patients confirm with suspected keratitis or ulcerative keratitis then stop or discontinue the drug Interstitial lung disease (ILD) : • Xovoltib 40mg drug can leads to lung and breathing problems. Inform doctor right away about new or worsening lung problems while taking this drug. These problems can involveDyspnea, cough, or fever. Bullous and exfoliative skin disorder : • Xovoltib 40mgcan affect skin severely and show redness, rash, and acne. Inform doctor right away if you affected by severe skin reactions such as peeling or blistering. Embryo-fetal toxicity: • Xovoltib 40mg will cause harm to the foetus when administrated to pregnant women.

  6. DRUG INTERACTION • Concomitant of Xovoltib 40mg with P-gpinhibitors (cyclosporine A, ketoconazole verapamil) will increase exposure to Afatinib • Interaction of Xovoltib 40mg with P-gpinducers (carbamazepine, phenytoin, phenobarbital) will decrease exposure to Afatinib

  7. STORAGE • Xovoltib40mgStore at 25℃. • KeepXovoltib 40mg away from children. MISSED DOSE • If patient missed to take the dose of Xovoltib 40mg,the missed dose should be skipped and follow the regular dosing schedule. Do not self-medicate. Do not double the dose.

  8. SIDE EFFECTS • Loss of appetite • Nausea • Vomiting • Diarrhoea • Mouth sores • Acne • Itchiness • Rash • Dry skin • Nail infection

  9. Serious side effects : • Breathing trouble • Cough and fever • Yellowing the skins • Brown coloured urine • Bleeding or bruising • Weakness • Blurred vision • Fast heartbeat

  10. Contact Us • phone No      :9987711567 • Email             :info@myapplepharma.com website • https://myapplepharma.com/afatinib-40mg.php

More Related